Our experience confirms and extends the findings of a previous case series on the use of daptomycin for the treatment of VRE UTIs. The previous study [12] of 5 hospitalized patients with ...

The aim of this study was to evaluate the effectiveness of daptomycin in the treatment of patients with vancomycin-resistant enterococcal urinary tract infection treated in our 200-bed community ...

Objective Daptomycin, a cyclic lipopeptide that exhibits rapid, concentration-dependent bactericidal activity in vitro against a broad spectrum of Gram-positive pathogens, has now, since 2003, been ...

The US Food and Drug Administration (FDA) has approved a novel antibiotic, daptomycin, for parenteral treatment of major abscesses and other skin and skin-structure infections. The approval “is very ...

Background Daptomycin is a concentration dependent antibiotic with particular sensitivity to strains of Staphylococcus aureus. Its novel mechanism of disrupting cell membranes makes it particularly ...